Frequency and prognostic impact of FLT3/ITD mutation in patients with acute myeloid leukaemia

Journal of B.U.ON.

Volumn 16, Issue 1, 2011, Pages 108-111

  Govedarovic, Nenad ^a   Marjanovic, G ^a  

^a CLINICAL CENTER NIS   (Serbia)

Author keywords

Acute leukaemia; FLT3; Mutation; Prognosis

Indexed keywords

CD135 ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; FEMALE; GENE FREQUENCY; GENE MUTATION; HUMAN; LEUKEMIA RELAPSE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREVALENCE; PROGNOSIS; SERBIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FMS-LIKE TYROSINE KINASE 3; HUMANS; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MUTATION; PROGNOSIS; TANDEM REPEAT SEQUENCES;

EID: 79954551093     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Deschler B, Lubbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer 2006; 107: 2099-2107. (Pubitemid 44665642)
2. Gari M, Abuzenadah A, Chaudhary A et al. Detection of FLT3 Oncogene Mutations in Acute Myeloid Leukemia Using Conformation Sensitive Gel Electrophoresis. Int J Mol Sci 2008; 9: 2194-2204.
3. Reilly JT. FLT3 and its role in the pathogenesis of acute myeloid leukaemia. Leukemia Lymphoma 2003; 44: 1-7. (Pubitemid 36113823)
4. Kayser S, Schlenk RF, Londono MC et al. Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome. Blood 2009; 114: 2386-2392.
5. Fröhling S, Schlenk RF, Breitruck J. Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm. Blood 2002; 100: 4372-4380. (Pubitemid 35434129)
6. Yamamoto Y, Kiyoi H, Nakano Y et al. Activating mutations of D835 within the activating loop of FLT3 in human hematologic malignancies. Blood 2001; 97: 2434-2439. (Pubitemid 32291491)
7. Fröhling S, Scholl C, Levine RL. Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate alleles. Cancer Cell 2007; 12: 501-513. (Pubitemid 350199072)
8. Kang HJ, Hong SH, Kim IH et al. Prognostic significance of FLT3 mutations in pediatric non-promyelocytic acute myeloid leukemia. Leuk Res 2005; 29: 617-623. (Pubitemid 40603560)
9. Abu-Duhier FM, Goodeve AC, Wilson GA et al. FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group. Br J Haematol 2000; 111: 190-195.
10. Peng HL, Zhang GS, Gong FJ et al. Fms-like tyrosine kinase (FLT) 3 and FLT3 internal tandem duplication in different types of adult leukemia: analysis of 147 patients. Croat Med J 2008; 49: 650-669.
11. Thiede C, Steudel C, Mohr B et al. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 2002; 99: 4326-4335. (Pubitemid 34627197)